Psoriasis is a chronic, inflammatory and proliferative disease which has a tendency to recur. Metabolic disturbances occur more often in patients with psoriasis in comparison to the general population. Due to the systemic inflammation and metabolic disturbances in psoriasis the risk of cardiovascular diseases is significantly higher. The data on higher cardiovascular risk which accompanies psoriasis suggest that every patient with psoriasis or psoriatic arthritis should be screened for metabolic disturbances. Patients with psoriasis should be under special care of general practitioner in order to prevent, diagnose and treat metabolic disturbances early.